Pain Reduction Improves Adherence, Quality of Life, and Work Capacity in Rheumatoid Arthritis Patients Receiving Baricitinib: Czech ATTRA Registry Analysis

Key Points

• This research aims to evaluate the effects of baricitinib on pain reduction and its impact on adherence and quality of life in rheumatoid arthritis patients.
• Analyzed data from the Czech ATTRA registry
• Focused on patients receiving baricitinib treatment
• Examined changes in pain levels, disease activity, and quality of life
• Baricitinib treatment led to sustained pain reduction
• Decreased disease activity was observed in patients
• Improvements in quality of life and work capacity were noted